期刊文献+

基于常规实验室检查的良恶性胸/腹水鉴别诊断模型研究 被引量:3

A model based on conventional laboratory parameters for differential diagnosis of malignant and benign pleural and peritoneal effusions
下载PDF
导出
摘要 目的分析常规实验室检查结果对胸/腹水良恶性质的鉴别诊断价值,并建立简便的数学诊断模型。方法查阅胸/腹水患者的病案资料,核实病因诊断,收集血细胞分析、血生化检查、胸/腹水常规及生化检查、血清肿瘤标志物检测结果等。单因素Logistic回归分析各项检查单项对良恶性胸/腹水的鉴别诊断价值,多因素Logistic回归分析建立数学诊断模型,并评价其对恶性胸/腹水的诊断价值。结果常规实验检查的27项单项指标中有13项对胸/腹水性质有鉴别诊断价值(P=0.000-0.018)。血白细胞计数、血总胆红素、胸/腹水Rivalta试验和血CEA进入数学模型,该模型诊断恶性胸/腹水的敏感度为89.2%,准确度为85.8%,均高于细胞学和染色体检查,特异度为81.3%,低于后两者。结论部分常规实验室检查的单项指标对良恶性胸/腹水的鉴别诊断具有一定的价值,由常规实验室检查的4项单项指标建立的数学模型对良恶性胸/腹水的鉴别具有较大的价值。 Objective To analyze the values of conventional laboratory parameters in differential diagnosis of malignant and benign pleural and peritoneal effusions and establish a simple diagnostic model based on thems. Methods The medical records of each patient with pleural or peritoneal effusion was reviewed retrospectively and the etiological diagnosis was verified. The following data were collected: blood cell analysis, serum biochemistry, effusion routine and biochemistry, serum tumor biomarkers. Univariate Logistic regression was performed to analyze the diagnostic value of each laboratory parameter, and multivariate Logistic regression was performed to establish a mathematical model and its diagnostic performance was evaluated. Results Thirteen of 27 single parameters were significant in differentiating nmlignant effusions from benign ones (P = 0. 000- 0. 018). The parameters entered the model were blood white cell count, total bilimbin, Rivalta test and carcinocmbryonic antigen. The sensitivity and accuracy of the model in malignant effusion diagnosis were 89.2% and 85.8 %, higher than cytology and chromosome analyses, and specificity 81.3 %, lower than them. Conclusion Some of conventional laboratory parameters are significant for differentiating malignant from benign effusions, and the mathematical model based on 4 parameters is simple and valuable in the differential diagnosis.
出处 《中国实验诊断学》 北大核心 2010年第4期551-555,共5页 Chinese Journal of Laboratory Diagnosis
基金 江西省主要学科学术与技术带头人计划资助(编号:030002)
关键词 胸水 腹水 鉴别诊断 数学模型 Pleural effusion Peritoneal effusion differential diagnosis diagnostic model
  • 相关文献

参考文献20

  • 1袁帅,张焜和.恶性胸/腹水的实验诊断研究现状[J].中国实验诊断学,2008,12(6):815-817. 被引量:7
  • 2Oyafuso MS,Longatto Filho A,Bortolan J,et al.Cytological diagnosis of serous effusions in a cancer hospital in Brazil[J].Pathologica,1996,88(2):128.
  • 3Pereira TC,Saad RS,Liu Y,et al.The diagnosis of malignancy in effusion cytology:a pattern recognition approach[J].Adv Anat Pathol,2006,13(4):174.
  • 4Metzgeroth G,Kuhn C,Schultheis B,et al.Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions[J].Cytopathology,2008,19(4):205.
  • 5He DN,Zhu HS,Zhang KH,et al.E-cadherin and calretinin as immunocytochemical markers to differentiate malignant and benign serous effusions[J].World J Gastroenterol,2004,10(16):2406.
  • 6Mohanty SK,Dey P.Serous effusions:diagnosis of malignancy beyond cytomorphology.An analytic review[J].Postgrad Med J,2003,79(936):569.
  • 7Braunschweig R,Guilleret I,Delacretaz F,et al.Pitfalls in TRAP assay in routine detection of malignancy in effusions[J].Diagn Cytopathol,2001,25(4):225.
  • 8Zhang KH,Cao F,Fu QB,et al.Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values[J].Intern Med,2007,46(18):1489.
  • 9Passebosc-Faure K,Li G,Lambert C,et al.Evaluation of a Panel of Molecular Markers for the Diagnosis of Malignant Serous Effusions[J].Clin Cancer Res,2005,11:6862.
  • 10陈明.医学数据挖掘综述[J].医学信息,2008,21(1):19-21. 被引量:10

二级参考文献61

共引文献50

同被引文献51

  • 1杨幼林,马志斌,徐洪雨.端粒酶检测在良恶性腹水鉴别诊断中的价值[J].中华内科杂志,2005,44(10):745-747. 被引量:11
  • 2鄢斌,刘军,李承彬,李俊立,王昌富.Logistic回归和ROC曲线综合分析组合项目对胸腹水性质的鉴别价值[J].中国误诊学杂志,2006,6(15):2876-2879. 被引量:7
  • 3Coughlin SM,Emmerton-Coughlin HMA,et al.Management of chest tubes after pulmonary resection[J].Canadian J Surg,2012,55(4):264-270.
  • 4Warwick WJ,Lee YW.The trapezoid waveform high frequency chest compression therapy increases water secretion[J].Biomed Instrum Technol,2009,43(3):241-243.
  • 5Du T,Zamore PD.MicroPrimer:the biogenesis and function of microRNA[J].Development,2005,132(1):4645-4652.
  • 6Chang SH,Hla T.Gene regulation by RNA binding proteins and microRNAs[J].Trends Mol Med,2011,17(11):650-658.
  • 7Calin GA,Liu CG.MicroRNA prof iling reveals distinct signatures in B cell chronic lymphocytic[J].Proc Natl Acad Sci USA,2004,101(5):11755-11760.
  • 8Calin GA,Sevignani C.Human microRNA genes are frequently located at fragile sites[J].Proc Natl Acad Sci USA,2004,105(9):2999-3004.
  • 9Eis PS,Tam W.Accumulation of miR-221 and BIC RNA in human B cell lymphomas[J].Proc Natl Acad Sci USA,2005,102(8):3627-3632.
  • 10Lee EJ,Gusev Y.Expression profiling identifies microRNA signature[J].Int J Cancer 2007,120(1):1046-1054.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部